A Bioequivalence Study Of Ethinylestradiol + Gestodene In Female And Healthy Volunteers.
Status:
Completed
Trial end date:
2010-10-01
Target enrollment:
Participant gender:
Summary
A Phase I, Open Label, Randomized, Two-way Crossover, Single Dose Study to Determine the
Bioequivalence of Ethinylestradiol + Gestodene - The objective of the study is to verify
through a single dose study, if the two formulations of Ethinylestradiol 0,02mg + Gestodene
0,075mg sugar coated tablets are bioequivalent when administered at the same dose and under
fasting conditions.